首页> 外国专利> Antiganic composition comprising whole killed or attenuated pathogenic eschrichia coli ( e.coli) cells for intradermal or subcutaneous administration for treating a human patient for crohn's disease

Antiganic composition comprising whole killed or attenuated pathogenic eschrichia coli ( e.coli) cells for intradermal or subcutaneous administration for treating a human patient for crohn's disease

机译:包含完整的被杀死的或减毒的致病性大肠杆菌(e.coli)细胞的抗原组合物,用于皮内或皮下给药以治疗人类患者的克罗恩病

摘要

The invention provides methods of formulating an anti-inflammatory composition for treating inflammatory conditions in a specific organ or tissue. The method involves selecting at least one pathogen that is pathogenic in the specific organ or tissue; producing an antigenic composition comprising antigenic determinants that together are specific for the pathogen; and formulating the antigenic composition for administration as an anti-inflammatory composition capable of eliciting an anti-inflammatory response in the specific organ or tissue, wherein the condition characterized by inflammation is not a cancer. In embodiments of the invention, a cancer is situated in the specific organ or tissue.
机译:本发明提供了配制用于治疗特定器官或组织中的炎性病症的抗炎组合物的方法。该方法包括选择至少一种在特定器官或组织中具有致病性的病原体。产生包含抗原决定簇的抗原组合物,所述抗原决定簇一起对病原体具有特异性;将抗原性组合物配制成能够在特定器官或组织中引起抗炎反应的抗炎组合物,其中以炎症为特征的疾病不是癌症。在本发明的实施方案中,癌症位于特定器官或组织中。

著录项

  • 公开/公告号IL224048A

    专利类型

  • 公开/公告日2020-09-30

    原文格式PDF

  • 申请/专利权人 QU BIOLOGICS INC.;

    申请/专利号IL20120224048

  • 发明设计人

    申请日2012-12-31

  • 分类号A61K39;A61K39/008;A61K39/02;A61K39/05;A61K39/085;A61K39/09;A61K39/095;A61K39/102;A61K39/104;A61K39/108;A61K39/112;A61K39/12;A61P1;A61P1/02;A61P1/04;A61P19/02;A61P29;A61P35;A61P37/04;A61P43;G01N33/48;G01N33/569;

  • 国家 IL

  • 入库时间 2022-08-21 11:17:19

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号